Issue link: https://viewer.e-digitaledition.com/i/538303
By Jennifer Webster THESE DEVICES TAKE INNOVATIVE APPROACHES TO FIGHTING INFECTION, HELPING HEALTHCARE WORKERS PERFORM STRENUOUS TASKS AND STREAMLINING CARE FOR PATIENTS. PRODUCT SPOTLIGHT Advances in Infection Control, Provider Safety and Patient Convenience Silk Road to Infection Control As surgeons look for antibiotic delivery systems that won't need subsequent removal, silk may not be the obvious option. However, silk and magnesium were key components of the approach researchers from Tufts University, Shanghai Institute of Microsystem and Information Technology, and the University of Illinois at Urbana-Champaign presented at a recent IEEE MEMS conference. A tiny electronic implant consisting of a coil and resistor made of magnesium and folded into a silk pocket was used subdermally to cure staph infections in mice. The scientists wirelessly activated the implant for two 10-minute intervals, producing heat and killing bacteria. In another version, ampicillin was added to the silk and magnesium delivery device, which released the drug when heated. Magnesium and silk both dissolve in the body, and researchers note that they can modify the crystalline structure of silk so that it degrades in anything from weeks to mere minutes. Giving Healthcare Workers a Lift German researchers are design- ing a vest that harnesses energy from healthcare providers' own movements to help them safely perform strenuous tasks such as lifting patients. The CareJack vest, which can be worn over workers' clothing, gathers kinetic energy created when a provider bends to lift a patient or to perform some other task then releases the energy when it is needed, say researchers with the Fraunhofer Institute for Production Systems and Design Technology IPK and the Fraunhofer Institute for Reliability and Microintegration IZM, the organizations spearheading development. In addition, the vest uses sensors to assess a worker's movements. Improper form while lifting activates a warning lamp. Synthetic actuators whose level of rigidity can be adjusted aid wearers by supporting correct movement. A prototype is expected this year. Researchers say the vest ultimately could be useful not only for healthcare providers but for workers in other physically taxing fi elds, such as construction or roofi ng. Streamlining Ancillary Treatments after Chemotherapy M y e l o s u p p r e s s i v e chemotherapy can cause neutropenia, which, com- bined with fever, can lead to infection and hospital- ization. After receiving c hemot her a p y, m a ny patients are prescribed pegfi lgrastim (Neulasta), a leucocyte growth factor, to combat low white blood cell count. Pegfi lgrastim is typically administered via injection just over 24 hours after chemotherapy. Some patients self-inject at home, whereas others return to the chemotherapy center. However, either option presents dilemmas for patients who cannot easily travel or cannot self-inject with confi dence. In response, manufacturer Amgen has introduced the Neulasta Delivery Kit with On-body Injector. A healthcare provider fi lls the injector using a pre-fi lled syringe, and the delayed-delivery device's adhesive backing permits attachment to the abdomen or back of the arms immediately following chemotherapy. The provider then supervises as the device inserts a subcutaneous cannula, which is primed to inject pegfi lgrastim about 27 hours later. ■ Image © Fraunhofer IPK/IZM Image courtesy of Tufts University M D N E W S . CO M ■ MD NEWS Long Island | 1 5

